2026 CMS Skin Substitute Reimbursement Overhaul: Desk Reference for Wound Care Providers The 2026 CMS Physician Fee Schedule introduces sweeping reforms to how skin substitutes—commonly referred to as cellular and tissue-based products (CTPs)—are reimbursed under Medicare Part B. These updates fundamentally change payment methodology, billing mechanics, and compliance expectations. For providers, these changes are not […]

WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection TAMPA, Fla., Sept. 2, 2025 /PRNewswire/ — WoundGenex, the industry leader in wound care revenue cycle and practice management solutions, and Shoreline Medical Administration, a premier healthcare support partner specializing in safeguarding Medicare reimbursements in the skin substitute space by […]

On the surface, the recent delay of the new Medicare LCD for skin substitutes to January 2026 may appear to be a win for providers and patients alike. After all, the proposed LCDs raised numerous concerns around access, frequency limits, and clinical documentation requirements.